For Biosimilars Under Medicare, It Is Just The Beginning
On March 30, 2015, in the wake of the first biosimilar product licensed by the U.S. Food and Drug Administration, the Centers for Medicare and Medicaid Services issued several guidance documents...To view the full article, register now.
Already a subscriber? Click here to view full article